Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2020

Jul 16, 2020

29819_dirs_2020-07-16_7c7c0b3e-4019-4c82-ae53-8e71d13ff086.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-07-15

Reporting Person: AMGEN INC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-15 Ordinary Shares A 29614832 $14.2308 Acquired 236249845 Direct

Footnotes

F1: Includes 206,635,013 securities represented by American Depositary Shares, each of which represents 13 Ordinary Shares of the Issuer.